01223 266900 Enquire
Please type into the search bar above to begin your search
Please type three or more characters above to begin your search
Please type into the search bar above to begin your search
Please type three or more characters above to begin your search
Consultant image

Practising at

Spire Cambridge Lea Hospital
View availability
Tel: 01223 266900

Clinic times

Monday: 2.30pm - 4.30pm
Wednesday: 1.30pm - 6pm
Thursday: 8am - 12.30pm

An initial consultation with Mr Philip Alexander is from £250.

Mr Philip Alexander

Consultant Ophthalmic Surgeon

BSc, MBBS, MBA, DIC, DM, FRCOphth

"Outstanding facilities, exceptional staff."

Specialises in

  • Cataract surgery
  • Diabetic eye disease
  • Refractive lens exchange surgery
  • Retinal detachment

Also available for:

Virtual consultations:

Make an enquiry View availability

Mr Alexander is a Consultant Ophthalmologist with particular expertise in cataract and vitreoretinal surgery.

Mr Alexander graduated from the University of London in 2002 with Distinction and a number of academic prizes. He gained comprehensive training in all aspects of Ophthalmology, and has completed advanced subspecialist surgical training in Nottingham, Southampton and at Moorfields Eye Hospital, London. He is currently a Consultant Ophthalmic and Vitreoretinal Surgeon at Cambridge University Hospitals, and is part of the team running the Stickler Syndrome Diagnostic Service commissioned by NHS England.

Mr Alexander trains Ophthalmologists on the East of England Specialist Training Programme, and trains Vitreoretinal Surgical Fellows at Addenbrooke’s Hospital.

Mr Alexander’s MBA thesis focussed on healthcare innovation for patients with diabetic eye disease.

In 2016, Mr Alexander was invited to attend the Ophthalmology Honours ceremony at the Royal College of Surgeons, where the Stickler Syndrome Service at Cambridge University Hospitals was given the Judge’s Special Award in recognition of the “highly specialised” and “world class” service that it delivers.

Read more...

General Medical Council Number: C6056731

Treatment information

Some of the principal treatments carried out by Mr Philip Alexander at Spire include:

Ophthalmology

Other treatments

  • Cataract surgery
  • Diabetic eye disease
  • Epiretinal membrane
  • Floater
  • Macular hole
  • Posterior capsular opacification following cataract surgery
  • Retinal detachment
  • Vitreomacular traction
  • Vitreous haemorrhage

Get in touch

Important information about COVID-19 tests

COVID-19 testing or antibody tests are not available as a standalone service at Spire Cambridge Lea Hospital.

88935
True
consultant
Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.


Additional information

MBBS (Distinction) / University of London / 2002
Bachelor of Medicine, Bachelor of Surgery

Professional memberships

Fellow of the Royal College of Ophthalmologists

He has over 45 publications in the scientific literature, and in 2013 was awarded funding from the Global Ophthalmology Awards Programme (GOAP) to conduct research into ocular stem cell transplantation, for which he later received a doctorate. He has presented his work at national and international meetings, and at the Houses of Parliament.

Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust 

Co-Founder and CEO of VisusNano Ltd, a privately held pre-clinical company developing a drug-eluting intraocular lens implant, for use in patients undergoing cataract surgery. This novel medical device will improve patient outcomes, and zliminate the need for eye drops after surgery. VisusNano Ltd has won several awards, including Oxford Biostars 2016.